PHARMA MAR, S.A. (PMRA.F)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in EUR.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 100M 200M 300M Q4 '20: 270M Q4 '21: 229.8M Q4 '22: 196.3M Q4 '23: 158.2M Q4 '24: 174.9M Q4 '20 Q4 '21 Q4 '22 Q4 '23 Q4 '24

Gross Profit Annual

0 90M 180M 270M Q4 '20: 256.2M Q4 '21: 213.4M Q4 '22: 182.7M Q4 '23: 148.5M Q4 '24: 166.7M Q4 '20 Q4 '21 Q4 '22 Q4 '23 Q4 '24

Operating Income Annual

-60M 0 60M 120M 180M Q4 '20: 155.9M Q4 '21: 92.4M Q4 '22: 44.1M Q4 '23: -3.8M Q4 '24: 6.5M Q4 '20 Q4 '21 Q4 '22 Q4 '23 Q4 '24

Net Income Annual

0 50M 100M 150M Q4 '20: 137.3M Q4 '21: 92.9M Q4 '22: 49.4M Q4 '23: 1.1M Q4 '24: 26.1M Q4 '20 Q4 '21 Q4 '22 Q4 '23 Q4 '24

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

-100M 0 100M 200M 300M Q4 '20: 278.9M Q4 '21: 25.7M Q4 '22: 38.3M Q4 '23: -13.4M Q4 '24: 6M Q4 '20 Q4 '21 Q4 '22 Q4 '23 Q4 '24

Free Cash Flow Annual

-30M -20M -10M 0 10M 20M 30M Q4 '23: -28.3M Q4 '24: -9M Q4 '23 Q4 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.